Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014690
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
2001-04-10
Brief Title:
ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
Sponsor:
AstraZeneca
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-02
Completion Date Type:
ACTUAL
First Submit Date:
2001-04-10
First Submit QC Date:
February 25 2004
Study First Post Date:
2004-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-01
Last Update Post Date:
2013-08-02
Last Update Post Date Type:
ESTIMATED